Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-25 @ 3:09 AM
NCT ID:
NCT01710605
Eligibility Criteria:
Inclusion Criteria:
* Women with metastatic ductal adenocarcinoma breast cancer
* 18 years old or more
* Hormone receptors positive breast cancer (ER+ and/or PR+) on the last pathological analysis available.
* Acceptable patient's clinical situation compatible with chemotherapy or hormonotherapy administration
* PS \<4
* Life expectancy \> 3 months
* Evidence of measurable or evaluable disease (RECIST 1.1 criteria)in the 28 days before selection
* Information of the patient and signature of the informed consent form
Exclusion Criteria:
* Patient treated by chemotherapy or hormonotherapy for their metastatic disease (treatment failure under adjuvant hormonotherapy are accepted)
* Her2 positive breast cancer
* History of other stage II or III cancer in the 5 years. History of other metastatic cancer (whatever the time between the two cancers).
* Persons deprived of their freedom or under guardianship.
* Women unable to comply with the medical follow-up of the study for geographical, social or mental reasons.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01710605
Study Brief:
Protocol Section:
NCT01710605